Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Flows from Operating Activities
Net loss	$ (2,603)	$ (1,812)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization expense - intangible asset	160	160
Amortization of debt discount	154	56
Common stock issued in connection with shareholder dispute		913
Financing costs in connection with the conversion of accounts payable	670
Stock-based compensation	218
Warrants issued in connection with convertible notes payable	29
Gain on settlement of accounts payable	(599)
Changes in operating assets and liabilities:
Vendor advances	(2,358)
Prepaid expenses and other current assets	(30)	(8)
Accounts payable and accrued expenses	404	772
Net cash provided by (used in) operating activities	(3,955)	81
Cash Flows from Financing Activities
Proceeds from common stock issued for cash in connection with the closing of the initial public offering	5,524
Proceeds from notes payable - officers	142
Repayment of notes payable - officers	(142)
Payment of deferred offering costs	(390)	(425)
Net cash provided by (used in) financing activities	5,134	(425)
Net increase (decrease) in cash	1,179	(344)
Cash beginning of year	93	437
Cash end of year	1,272	93
Supplemental cash flows disclosures:
Interest paid	3
Taxes paid
Supplemental non-cash financing disclosures:
Issuance of common shares for deferred offering costs	1,377
Issuance of common shares for vendor advances	500
Reclassification of deferred offering costs to shareholders’ equity	872
Conversion of convertible notes payable and accrued interest to shareholders’ equity	884
Conversion of accounts payable to shareholders’ equity	1,348
Conversion of amounts due to related parties to shareholders’ equity	4
Issuance of convertible notes payable recorded as debt discount	$ 49	$ 68